Braidwell »

Maravai Lifesciences Holdings shares owned by Braidwell

Quarter-by-quarter ownership of Maravai Lifesciences Holdings (MRVI) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Maravai Lifesciences Holdings

Tip: Access up to 7 years of quarterly data

All positions including Maravai Lifesciences Holdings held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maravai Lifesciences Holdings by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $33M 5.0M 6.55
2023-09-30 $40M 4.0M 10.00
2023-06-30 $22M 1.8M 12.43

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Maravai Lifesciences Holdings

Vanguard Group
Massachusetts Financial Services
Millennium Management
Mackenzie Financial
Braidwell
AQR Capital Management
Alyeska Investment Group
Pacer Advisors
Marshall Wace
Point72 Europe
Hudson Bay Capital Management
Bamco
Two Sigma Advisers
Deutsche Bank Aktiengesellschaft
Systematic Financial Management

View all funds holding Maravai Lifesciences Holdings